MRSN
USDMersana Therapeutics Inc. Common Stock
リアルタイム価格
価格チャート
主要指標
市場指標
始値
$9.065
高値
$9.065
安値
$8.000
出来高
0.03M
企業ファンダメンタルズ
時価総額
40.7M
業種
バイオテクノロジー
国
United States
取引統計
平均出来高
0.07M
取引所
NMS
通貨
USD
52週レンジ
関連ニュース
Truist Securities Maintains Buy on Mersana Therapeutics, Adjusts Price Target To $36 from $250
Truist Securities analyst Asthika Goonewardene maintains Mersana Therapeutics with a Buy, Adjusts Target to $36 from $250
Guggenheim Maintains Buy on Mersana Therapeutics, Lowers Price Target to $30
Guggenheim analyst Michael Schmidt maintains Mersana Therapeutics with a Buy and lowers the price target from $125 to $30.
Mersana Therapeutics, Inc. (MRSN) Q2 2025 Earnings Call Transcript
Mersana Therapeutics, Inc. (MRSN) Q2 2025 Earnings Call Transcript
Mersana Therapeutics Provides Business Update and Announces Second Quarter 2025 Financial Results
More than 45 patients enrolled in Emi-Le Phase 1 dose expansion cohorts in post-topoisomerase-1 inhibitor ADC (post-topo-1) triple-negative breast cancer (TNBC)Plan to report initial clinical data from Emi-Le expansion
Mersana Therapeutics to Host Second Quarter 2025 Conference Call on August 13, 2025
CAMBRIDGE, Mass., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on the development of antibody-drug conjugates (ADCs) targeting cancers
